“…The NAFLD spectrum starts with simple steatosis or lipid deposition within the liver. Left untreated, steatosis can progress to nonalcoholic steatohepatitis (NASH), i.e., steatosis accompanied by inflammation of the liver, NASH with fibrosis, cirrhosis and finally hepatocellular carcinoma (HCC) [ 3 , 4 , 5 , 6 , 7 , 8 ]. Considering that ~30% of the population in the United States alone has some steatosis, the risk for a NASH epidemic looms large [ 1 ].…”